17 July 2020

City gears up for rush of corporate takeovers sparked by Covid

Ivan Sedgwick, Investment Director, contributed to an article in the Evening Standard on a potential rush of corporate takeovers.

Ivan Sedgwick, investment director at mid-cap corporate advisor LGB & Co, sounded a note of caution: “For the rest of the year, the queue of companies shoring up their balance sheets may eventually soak up demand; we’ve been told about the huge dry powder available to private equity funds, but this is not money in the bank, and there’s no certainty as to when they’ll commit it.”

To read the full article, please click here.

Recent Articles

7 September 2020

Back British biotech by improving the clinical trials process

Andrew Boyle, CEO of LGB & Co. Limited, wrote an article for Pharmiweb on how to improve the British biotech sector.

Read more

News & Insights

1 September 2020

Is it safe to get back in the water? SME credit investments in the post-Covid world

Please join us to hear from our expert panel on how investors are viewing the market and assessing SME risk and resilience over the next 6 months and beyond. Read more

News & Insights

27 August 2020

COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts

Andrew Boyle, CEO of LGB & Co. Limited, wrote an article published in PharmaPhorum on the impact COVID-19 is having on the biotech sector in the UK.

Read more

News & Insights